Identifying cases of Takotsubo cardiomyopathy in Scotland
Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland - the STARR Study
University of Aberdeen · NCT03299569
This study is trying to find out how many people in Scotland have Takotsubo cardiomyopathy, a stress-related heart condition, and how it affects their health compared to others with heart issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 800 (estimated) |
| Sex | All |
| Sponsor | University of Aberdeen (other) |
| Locations | 1 site (Aberdeen, Scotland) |
| Trial ID | NCT03299569 on ClinicalTrials.gov |
What this trial studies
This study aims to establish the incidence of Takotsubo cardiomyopathy, a condition that mimics a heart attack but is triggered by acute stress, in Scotland since 2010. Public Health Scotland will identify patients diagnosed with this condition using specific health codes and will cross-check their clinical data to confirm diagnoses. The study will also create a registry of confirmed Takotsubo cases and compare clinical outcomes with matched control populations, including individuals from the general population and patients with myocardial infarction. Data will be collected both retrospectively and prospectively to assess outcomes and treatment patterns.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with Takotsubo cardiomyopathy.
Not a fit: Patients who do not have a diagnosis of Takotsubo cardiomyopathy will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of Takotsubo cardiomyopathy and improve patient management strategies.
How similar studies have performed: While this study focuses on incidence and epidemiology, similar studies have shown success in understanding the outcomes of Takotsubo cardiomyopathy.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients diagnosed with Takotsubo cardiomyopathy Exclusion Criteria: * NA
Where this trial is running
Aberdeen, Scotland
- Cardiac Research Office — Aberdeen, Scotland, United Kingdom (RECRUITING)
Study contacts
- Principal investigator: Dana Dawson, MD, MRCP — University of Aberdeen
- Study coordinator: Dana Dawson, MD, MRCP
- Email: dana.dawson@abdn.ac.uk
- Phone: 01224 437969
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Takotsubo Cardiomyopathy, Myocardial Infarction